FDAFDA recall D-0850-2026 · Sep 16, 2026
Baxter Healthcare Corporation: Dextrose Injection recall
Recall found
Product
Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL, 60016, Made in USA, NDC 00338-0719-06
Reason for recall
Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.
What to do
FDA enforcement reports don't include consumer instructions. Check the codes below against your packaging. If this is a medicine or device you use, talk to your pharmacist or doctor before you stop or change anything, and contact the company or FDA for what to do with the product.
Recall details
- FDA classification
- Class I: FDA's most serious class, where use of or exposure to the product may cause serious health problems or death.
- Status
- Ongoing
- Codes, lots and dates
- Lot #: Y495066, Exp. Date July 31, 2027
- Quantity
- 606 bags
- Distribution
- U.S. Nationwide.
- Recalling firm
- Baxter Healthcare Corporation, Deerfield, IL
- Voluntary or mandated
- Voluntary: Firm initiated
- Recall started
- 2026-08-17
Source: openFDA enforcement record D-0850-2026 · search recall number D-0850-2026 in FDA's Enforcement Report.
Copied from the agency record without changes. Data as of Oct 22, 2026, 4:56 AM EDT. The agency notice is the final word.